Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections

التفاصيل البيبلوغرافية
العنوان: Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections
المؤلفون: Jarl Hellman, Thomas Nyström, Marcus Lind, William H. Polonsky, Arndís F. Ólafsdóttir, Anders Frid, Hans Wedel, Tim Heise, Erik Schwarz, Elsa Ahlén, Irl B. Hirsch, Jan Bolinder, Sofia Dahlqvist
المصدر: JAMA. 317:379
بيانات النشر: American Medical Association (AMA), 2017.
سنة النشر: 2017
مصطلحات موضوعية: Adult, Blood Glucose, Male, medicine.medical_specialty, Time Factors, medicine.medical_treatment, 030209 endocrinology & metabolism, Drug Administration Schedule, Medication Adherence, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Diabetes mellitus, Internal medicine, medicine, Humans, Hypoglycemic Agents, Insulin, Outpatient clinic, 030212 general & internal medicine, Adverse effect, Glycemic, Glycated Hemoglobin, Sweden, Type 1 diabetes, Cross-Over Studies, business.industry, General Medicine, Middle Aged, medicine.disease, Crossover study, Hypoglycemia, Surgery, Diabetes Mellitus, Type 1, Treatment Outcome, Patient Satisfaction, Female, business
الوصف: IMPORTANCE The majority of individuals with type 1 diabetes do not meet recommended glycemic targets. OBJECTIVE To evaluate the effects of continuous glucose monitoring in adults with type 1 diabetes treated with multiple daily insulin injections. DESIGN, SETTING, AND PARTICIPANTS Open-label crossover randomized clinical trial conducted in 15 diabetes outpatient clinics in Sweden between February 24, 2014, and June 1, 2016 that included 161 individuals with type 1 diabetes and hemoglobin A1c (HbA1c) of at least 7.5%(58 mmol/mol) treated with multiple daily insulin injections. INTERVENTIONS Participants were randomized to receive treatment using a continuous glucose monitoring system or conventional treatment for 26 weeks, separated by a washout period of 17 weeks. MAIN OUTCOMES AND MEASURES Difference in HbA1c between weeks 26 and 69 for the 2 treatments. Adverse events including severe hypoglycemia were also studied. RESULTS Among 161 randomized participants, mean age was 43.7 years, 45.3%were women, and mean HbA1c was 8.6%(70 mmol/mol). A total of 142 participants had follow-up data in both treatment periods. Mean HbA1c was 7.92%(63 mmol/mol) during continuous glucose monitoring use and 8.35%(68 mmol/mol) during conventional treatment (mean difference, -0.43%[95%CI, -0.57%to -0.29%] or -4.7 [-6.3 to -3.1 mmol/mol]; P < .001). Of 19 secondary end points comprising psychosocial and various glycemic measures, 6met the hierarchical testing criteria of statistical significance, favoring continuous glucose monitoring compared with conventional treatment. Five patients in the conventional treatment group and 1 patient in the continuous glucose monitoring group had severe hypoglycemia. During washout when patients used conventional therapy, 7 patients had severe hypoglycemia. CONCLUSIONS AND RELEVANCE Among patients with inadequately controlled type 1 diabetes treated with multiple daily insulin injections, the use of continuous glucose monitoring compared with conventional treatment for 26 weeks resulted in lower HbA1c. Furthe. (Less)
تدمد: 0098-7484
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81daac3fec84c0ca26edf7ceb235518cTest
https://doi.org/10.1001/jama.2016.19976Test
رقم الانضمام: edsair.doi.dedup.....81daac3fec84c0ca26edf7ceb235518c
قاعدة البيانات: OpenAIRE